NeoGenomics, Inc. (NEO)
NASDAQ: NEO · IEX Real-Time Price · USD
13.73
-0.20 (-1.44%)
Jul 2, 2024, 4:00 PM EDT - Market closed
NeoGenomics Employees
NeoGenomics had 2,100 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
2,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$290,792
Profits / Employee
-$40,111
Market Cap
1.75B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2,100 | 0 | - |
Dec 31, 2022 | 2,100 | 100 | 5.00% |
Dec 31, 2021 | 2,000 | 300 | 17.65% |
Dec 31, 2020 | 1,700 | 0 | - |
Dec 31, 2019 | 1,700 | 200 | 13.33% |
Dec 31, 2018 | 1,500 | 500 | 50.00% |
Dec 31, 2017 | 1,000 | 62 | 6.61% |
Dec 31, 2016 | 938 | 88 | 10.35% |
Dec 31, 2015 | 850 | 410 | 93.18% |
Dec 31, 2014 | 440 | 125 | 39.68% |
Dec 31, 2013 | 315 | 52 | 19.77% |
Dec 31, 2012 | 263 | 33 | 14.35% |
Dec 31, 2011 | 230 | 53 | 29.94% |
Dec 31, 2010 | 177 | 11 | 6.63% |
Dec 31, 2009 | 166 | 52 | 45.61% |
Dec 31, 2008 | 114 | 22 | 23.91% |
Dec 31, 2007 | 92 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Evotec SE | 4,952 |
Zai Lab | 2,175 |
Novavax | 1,543 |
NovoCure | 1,453 |
LeMaitre Vascular | 630 |
Immunocore Holdings | 497 |
Arvinas | 445 |
Rocket Pharmaceuticals | 268 |
NEO News
- 19 days ago - Fort Myers' Mayor to Proclaim June as NeoGenomics' Commitment to Cancer Month - Business Wire
- 23 days ago - Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing - GlobeNewsWire
- 5 weeks ago - NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management - Business Wire
- 2 months ago - NeoGenomics Reports First Quarter 2024 Results - Business Wire
- 2 months ago - NeoGenomics Announces Senior Leadership Promotions - Business Wire
- 3 months ago - NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024 - Business Wire
- 3 months ago - NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting - Business Wire
- 3 months ago - NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report - Business Wire